Infectious disease-associated encephalopathies.
Maria C Barbosa-SilvaMaiara N LimaDenise BattagliniChiara RobbaPaolo PelosiPatricia R M RoccoTatiana Maron-GutierrezPublished in: Critical care (London, England) (2021)
Infectious diseases may affect brain function and cause encephalopathy even when the pathogen does not directly infect the central nervous system, known as infectious disease-associated encephalopathy. The systemic inflammatory process may result in neuroinflammation, with glial cell activation and increased levels of cytokines, reduced neurotrophic factors, blood-brain barrier dysfunction, neurotransmitter metabolism imbalances, and neurotoxicity, and behavioral and cognitive impairments often occur in the late course. Even though infectious disease-associated encephalopathies may cause devastating neurologic and cognitive deficits, the concept of infectious disease-associated encephalopathies is still under-investigated; knowledge of the underlying mechanisms, which may be distinct from those of encephalopathies of non-infectious cause, is still limited. In this review, we focus on the pathophysiology of encephalopathies associated with peripheral (sepsis, malaria, influenza, and COVID-19), emerging therapeutic strategies, and the role of neuroinflammation.
Keyphrases
- infectious diseases
- blood brain barrier
- cerebral ischemia
- early onset
- traumatic brain injury
- coronavirus disease
- sars cov
- lipopolysaccharide induced
- oxidative stress
- healthcare
- cognitive impairment
- lps induced
- intensive care unit
- single cell
- acute kidney injury
- brain injury
- stem cells
- subarachnoid hemorrhage
- white matter
- cerebrospinal fluid
- inflammatory response
- spinal cord
- multiple sclerosis
- atomic force microscopy
- candida albicans
- mass spectrometry
- bone marrow
- mesenchymal stem cells
- respiratory syndrome coronavirus